UNFI’s distribution economics improved, but higher profit does not mean every extra dollar reaches shareholders. FY2027 guidance raises adjusted EBITDA while its free-cash-flow midpoint falls to $300M from $323M. Investment, financing and recurring adjustments still matter. Three explicit valuation routes blend to about $49; that is modest upside from $44.11 for a low-margin, leveraged business. We rate it HOLD, conviction 2/5, and want either a larger margin of safety or stronger evidence on cash conversion.
Illustrative twelve-month outcomes; probabilities and valuation multiples are Charged Alpha assumptions, not guidance.
| Scenario | Probability | 12-month value | vs $44.11 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 30% | $32.00 | −27% | Growth disappoints and cash remains constrained. | Analyst FY27 adjusted EBITDA $650M at 5.5x EV, less observed $1539M net debt, divided by 62.9M shares. Rounded to the nearest whole dollar. |
| Base | 50% | $49.00 | +11% | Guidance midpoint and a measured valuation prevail. | Rounded blend of three specified guidance-midpoint valuation routes. |
| Bull | 20% | $71.00 | +61% | Operations outperform and the market rerates the business. | Analyst FY27 adjusted EBITDA $800M at 7.5x EV, less observed $1539M net debt, divided by 62.9M shares. Rounded to the nearest whole dollar. |
| The weighted outcome is $48.30. It is separate from the $49 base fair value and is not a promised return. All scenarios retain the observed $1,539M net debt and 62.9M modeled diluted shares; no automatic future debt repayment is credited. | |||||
| Signpost | Now (Q4 FY2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| FY2027 FCF guide | $275–325M; $300M midpoint | Midpoint at least $300M while investment plan stays funded | Guide floor below $275M | Q1 FY2027 release, expected December 2026; date unconfirmed |
| Net leverage | 2.2x at August 1 | At or below 2.0x | Above 2.5x | Q1 FY2027 filing, expected December 2026 |
| Reported sales growth | Q4 −0.7%; FY2027 midpoint +1.1% | Quarterly growth above 0% with disclosed mix | Quarterly decline worse than 3% | Q1 FY2027 release, expected December 2026 |
| Adjusted EBITDA guide | $730–780M FY2027 | Midpoint at least $755M | Midpoint below $730M | Q1 FY2027 release, expected December 2026 |
| Transformation expense | $34M FY2026, $10M Q4 | Quarterly charge below $10M with operating delivery intact | Quarterly charge above $15M | Q1 FY2027 release, expected December 2026 |
| Buyback discipline | Q4 paid $49.94/share; new $200M authorization | Net share reduction at prices below our $49 value, without leverage rising | Repurchases above $54 while leverage exceeds 2.2x | Q1/Q2 FY2027 filings, expected December 2026/March 2027 |
These are prospective analyst thresholds, not management promises. We will compare the next packet with this dated baseline. No earlier packet scorecard was recovered, so we do not invent a grade for prior recommendations. Faster buybacks alone are not a green signal.
Price reference is the September 10 close; financial statements end August 1.
Nine-quarter statements were rebuilt from the actual earnings exhibits.
| Metric | Q4 FY2025 | Q4 FY2026 | FY2026 |
|---|---|---|---|
| Revenue | $7,696M | $7,642M | $31,152M |
| Gross profit | $1,030M | $1,050M | $4,196M |
| Operating income | −$78M | $69M | $211M |
| Net income attributable | −$87M | $35M | $84M |
| Diluted EPS | −$1.43 | $0.57 | $1.34 |
| Adjusted EBITDA | $116M | $172M | $701M |
| Adjusted EPS | −$0.11 | $0.69 | $2.65 |
| Free cash flow | $86M | $80M | $323M |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | |||
Gross segment sales include internal transactions; consolidated sales subtract eliminations.
| Segment | Q4 FY2026 | Year-over-year | Interpretation |
|---|---|---|---|
| Natural | $4,260M | +6.6% | Growth in the larger natural-food business |
| Conventional | $3,121M | −8.6% | Optimization and business mix matter |
| Retail | $528M | −7.9% | Do not assume the retail operation shares wholesale economics |
| Eliminations | −$267M | Internal transactions | Prevents double counting across segments |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | |||
GAAP, EBITDA and adjusted EPS answer different questions.
| FY2026 adjustment or claim | Amount | Why it matters |
|---|---|---|
| Depreciation and amortization | $303M | Asset consumption remains economically relevant |
| Share-based compensation | $61M | Noncash today, potentially dilutive |
| LIFO charge | $19M | Inventory accounting affects GAAP margin |
| Restructuring | $52M | Recurring presence across multiple years |
| Asset losses and charges | $27M | Includes impairments and receivable-sale economics |
| Business transformation | $34M | A repeated adjustment, not assumed permanently free |
| Cybersecurity adjustment | −$21M | Net recovery benefit removed from adjusted earnings |
| Net interest expense | $126M | Financing claim remains before equity cash flow |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | ||
A high cash-conversion ratio is a starting question, not an automatic quality award.
More investment is not necessarily bad; it must earn a return.
| Fiscal year | Operating cash | Capex | FCF | SBC |
|---|---|---|---|---|
| FY2024 | $253M | $345M | $-92M | $39M |
| FY2025 | $470M | $231M | $239M | $43M |
| FY2026 | $540M | $217M | $323M | $61M |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | ||||
Analyst multiples and cash yields, disclosed guidance and observed net debt.
14 × $3.25 = $45.50 per share. Weight 30%. The midpoint is management guidance; 14x is our chosen multiple. Repeated adjustments are why we do not pay a premium growth multiple.
6.5 × $755M − $1,539M = $3,368.5M equity value; divide by 62.9M modeled diluted shares = $53.55. Weight 30%. No projected debt reduction is silently credited.
$300M /10% = $3,000M equity value; divide by 62.9M shares = $47.69. Weight 40%. FCF already bears operating cash costs; subtracting net debt again here would double-charge a financing claim.
Freshly observed firm/date/target rows replace the inherited stale board.
| Firm | Observed action date | Rating | Target | Evidence basis |
|---|---|---|---|---|
| Roth Capital | 2026-09-10 | Neutral | $45, up from $43 | MarketBeat row plus FMP news headline |
| UBS | 2026-09-09 | Neutral | $50, up from $47 | MarketBeat row plus FMP news headline |
| BMO Capital | 2026-09-09 | Outperform | $61 | MarketBeat row and StreetInsider dated headline |
| BTIG Research | 2026-09-09 | Neutral | No target in observed row | MarketBeat row; no number inferred |
| Charged Alpha | 2026-09-11 | HOLD · 2/5 | $49 | Own disclosed three-route model |
| https://www.marketbeat.com/stocks/NYSE/UNFI/forecast/ | ||||
| FY2027 forward view | Revenue | EPS | Qualification |
|---|---|---|---|
| Management guide | $31.2–31.8B | $3.00–3.50 adjusted; $1.70–2.30 GAAP | Issuer fiscal year ends July 31, 2027 |
| FMP estimate snapshot | $31.73B average | $3.37 average | 6 revenue analysts/4 EPS analysts; vendor period label August 1; no pre-release snapshot |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | |||
FY2027 is a 52-week year; all ranges below are issuer guidance.
| Measure | FY2026 actual | FY2027 guide |
|---|---|---|
| Revenue | $31.152B | $31.2–31.8B |
| GAAP net income | $84M | $105–145M |
| GAAP EPS | $1.34 | $1.70–2.30 |
| Adjusted EPS | $2.65 | $3.00–3.50 |
| Adjusted EBITDA | $701M | $730–780M |
| Capital + cloud investment | $252M | About $300M |
| Free cash flow | $323M | $275–325M |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | ||
| Management test | Evidence now | Assessment |
|---|---|---|
| Execution | $147M operating-income improvement with a disclosed bridge | Positive, but gains and restructuring changes contribute |
| Investment | About $300M capital/cloud budget versus $252M | Returns still to demonstrate |
| Leverage | Net debt down $295M; company leverage 2.2x | Positive with operating-lease caveat |
| Capital allocation | $50M FY buybacks; $61M SBC; new $200M authority | Watch net shares and purchase price |
| Guidance discipline | Forward cash/profit ranges explicit; no complete forward reconciliation | Use ranges, not false precision |
| Disclosure | Q4 segment profit and full forward FCF bridge unavailable | Leave gaps visible |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | ||
Likelihood and impact are analyst judgments, not probability estimates supplied by management.
| Risk | Likelihood | Impact | What we watch |
|---|---|---|---|
| Customer concentration | Medium | High | Largest customer was about 25% of FY2025 revenue; contract through May 20, 2032 |
| Cash investment overshoot | Medium | High | FCF guide floor $275M and capital/cloud budget |
| Optimization loses durable business | Medium | High | New customer growth versus continued reported decline |
| Financing and lease commitments | Medium | High | $1,539M net debt plus $1,459M operating leases |
| Repeated adjusted-cost exclusions | High | Medium | Transformation/restructuring/SBC trends |
| Cyber or service disruption | Low–Medium | High | Recovery costs, service and working-capital effects |
| Labor and distribution inflation | Medium | Medium | 25,600 employees reported FY2025; 42% union-covered |
| Overpriced capital returns | Medium | Medium | Net dilution, buyback prices and leverage |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085925000054/unfi-20250802.htm | |||
Natural growth, new accounts and better service allow operating leverage to persist. Cash funds reinvestment and debt reduction; a higher multiple becomes defensible. Our bull scenario deliberately exceeds current EBITDA guidance and is not represented as management’s base case.
Optimization leaves a smaller revenue base, costs labeled temporary persist, and spending or working capital consumes the apparent cash yield. Low margins magnify service and wage pressures. A lower EBITDA multiple can offset operating improvement.
The recovery deserves credit; the current price does not provide our preferred 20% margin of safety. We want evidence that investment is paying off and the cash guide remains intact, rather than a favorable annual EPS comparison alone.
Dates beyond the current filing are expected windows unless the issuer confirms them.
| Window | Event | Decision relevance |
|---|---|---|
| September–October 2026, expected | FY2026 Form 10-K | Reconcile missing Q4 segment profit and full-year disclosures |
| December 2026, expected | Q1 FY2027 results | Check cash/EBITDA guidance, new sales and optimization drag |
| March 2027, expected | Q2 FY2027 results | Assess two-quarter service and investment evidence |
| June 2027, expected | Q3 FY2027 results | Test progress toward full-year cash range |
| Fiscal year ending July 31, 2027 | FY2027 operating period | Measure actual FCF versus $275–325M guidance |
| Any reported quarter | Repurchases, financing and customer changes | Update share count, debt and concentration evidence |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | ||
Missing disclosure is identified; reported and computed values stay separate.
| Period | Weeks | Sales$M | Gross$M | Operating$M | Net$M | EPS | Diluted sharesM |
|---|---|---|---|---|---|---|---|
| Q4 FY2024 | 14 | 8155.0 | 1116.0 | 2.0 | −37.0 | −0.63 | 59.5 |
| Q1 FY2025 | 13 | 7871.0 | 1038.0 | 5.0 | −21.0 | −0.35 | 59.6 |
| Q2 FY2025 | 13 | 8158.0 | 1072.0 | 27.0 | −3.0 | −0.05 | 60.2 |
| Q3 FY2025 | 13 | 8059.0 | 1082.0 | 15.0 | −7.0 | −0.12 | 60.5 |
| Q4 FY2025 | 13 | 7696.0 | 1030.0 | −78.0 | −87.0 | −1.43 | 60.6 |
| Q1 FY2026 | 13 | 7840.0 | 1051.0 | 19.0 | −4.0 | −0.06 | 60.7 |
| Q2 FY2026 | 13 | 7947.0 | 1046.0 | 57.0 | 20.0 | 0.31 | 62.7 |
| Q3 FY2026 | 13 | 7723.0 | 1049.0 | 66.0 | 33.0 | 0.52 | 62.7 |
| Q4 FY2026 | 13 | 7642.0 | 1050.0 | 69.0 | 35.0 | 0.57 | 62.9 |
| Actual earnings-exhibit statement columns; FY2024 Q4 had 14 weeks. Net is attributable to UNFI. EPS is reported, not divided from rounded net income. | |||||||
| Annual cash-flow line | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| OCF | 253 | 470 | 540 |
| Cash capex | 345 | 231 | 217 |
| Computed FCF | −92 | 239 | 323 |
| SBC | 39 | 43 | 61 |
| Common stock repurchases | 0 | 0 | 50 |
| USD millions. Fiscal 2024 had 53 weeks. Repurchases are outflow magnitudes; no common dividend assumed from a missing row. | |||
| August 1, 2026 balance-sheet item | USD millions |
|---|---|
| Cash | 37 |
| Receivables | 921 |
| Inventories | 1946 |
| Current assets | 3138 |
| Property/equipment | 1716 |
| Operating lease assets | 1334 |
| Goodwill | 19 |
| Intangibles | 509 |
| Total assets | 7109 |
| Accounts payable | 1771 |
| Current debt/finance leases | 5 |
| Long-term debt | 1561 |
| Long-term finance leases | 10 |
| Operating lease liabilities | 1459 |
| Total liabilities | 5487 |
| UNFI equity | 1621 |
| Noncontrolling interest | 1 |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | |
| Calculation | Method or result |
|---|---|
| Quarter operating bridge | 1050−984−12+15=69 |
| Quarter pretax/net bridge | 69+5−29+1=46;46−11=35 |
| Annual FCF | 540−217=323 |
| Company net debt | 5+1561+10−37=1539 |
| Receivable days | Average 1093/921 divided by 31152 annual sales×365 |
| Inventory days | Average 2095/1946 divided by 26956 annual cost of sales×365 |
| Route blend | 30%×45.50+30%×53.5533+40%×47.6948=48.7939 |
| Scenario-weighted price | 30%×32+50%×49+20%×71=48.30 |
| Conditional margin of safety | 49×80%=39.20 |
| Market-implied FCF at 10% yield | 2669.499265×10%=266.9499M |
| https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/f26q4earningsrelease.htm | |